Agenus | Spese Operative





Spese Operative Cambiamento Data
AbbVie USD 10.81B 13.45B 2025-12
Agenus USD -274.14M 80.46M 2025-09
Amgen USD 5.9B 773M 2025-12
AstraZeneca USD 16.69B 5.74B 2025-09
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Celldex Therapeutics USD 598.36M 533.78M 2025-09
CSL USD 2.87B 2.85B 2025-06
Dynavax Technologies USD 73.6M 7.41M 2025-09
Eli Lilly USD 10.31B 1.09B 2025-12
Gilead Sciences USD 4.26B 95M 2025-09
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Glaxosmithkline GBP 7.77B 2.22B 2025-09
Incyte USD 1.12B 3.53B 2025-12
Intrexon USD 61.56M 26.1M 2024-06
J&J USD 18.97B 2.38B 2025-12
Jiangsu Hengrui CNY 5.94B 254.97M 2025-09
Karyopharm Therapeutics USD 61.82M 3.24M 2024-12
MacroGenics USD 67M 8M 2025-09
Merck EUR 4.11B 117M 2025-09
Merck USD 10.16B 558M 2025-12
Novartis USD 9.86B 115M 2025-09
Novavax USD 218.53M 34.86M 2024-09
Pfizer USD 12.91B 79.89B 2025-12
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Veracyte USD 108.76M 7.09M 2025-09


Agenus Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.